Sarepta Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SRPT for the last quarter is 467.17 M USD, and it's 28.72% higher compared to the previous quarter. The net income of Q3 24 is 33.61 M USD.